| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 782 | 11.314 | 117.444 | 121.363 | 124.475 | 118.636 | 102.604 | 107.153 | 99.661 | 104.133 |
| Total Income - EUR | 782 | 11.314 | 117.444 | 121.679 | 124.475 | 118.636 | 102.604 | 110.523 | 100.552 | 104.133 |
| Total Expenses - EUR | 0 | 37 | 3.581 | 15.940 | 19.825 | 27.650 | 29.342 | 35.065 | 46.183 | 22.055 |
| Gross Profit/Loss - EUR | 782 | 11.277 | 113.863 | 105.738 | 104.650 | 90.986 | 73.262 | 75.458 | 54.369 | 82.078 |
| Net Profit/Loss - EUR | 759 | 10.938 | 110.340 | 102.097 | 100.916 | 87.680 | 70.184 | 73.218 | 53.429 | 78.954 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Sanomar Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 47.045 | 33.226 | 19.933 | 7.109 | 0 | 6.494 | 3.975 |
| Current Assets | 871 | 12.139 | 122.932 | 163.728 | 168.336 | 219.289 | 117.840 | 78.299 | 78.692 | 81.508 |
| Inventories | 0 | 0 | 20.513 | 20.136 | 21.474 | 18.350 | 54.580 | 26.554 | 272 | 270 |
| Receivables | 0 | 0 | 0 | 12.143 | 2.671 | 11.702 | 20.483 | 45.202 | 1.418 | 2.366 |
| Cash | 871 | 12.139 | 102.419 | 131.448 | 144.191 | 189.237 | 42.777 | 6.542 | 77.003 | 78.872 |
| Shareholders Funds | 759 | 11.689 | 121.830 | 166.315 | 164.098 | 213.849 | 96.291 | 73.266 | 86.617 | 84.237 |
| Social Capital | 0 | 0 | 0 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 112 | 451 | 1.102 | 45.447 | 38.434 | 33.317 | 32.758 | 8.212 | 2.001 | 4.658 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sanomar Medica Srl